Erectile Dysfunction (ED), also known as impotence, is the inability to maintain an erection of the penis necessary for sexual intercourse. Erectile dysfunction is mostly related to neurologic, vascular, hormonal, and psychological disorders. The excessive use of drugs may also lead to erectile dysfunction in many cases. Erectile dysfunction treatments are used to cure patients and can be done through drugs or devices.
The Canada erectile dysfunction treatment market was valued at US$ 292.3 Mn in 2018 and is expected to reach US$ 430.5 Mn by the year 2026, growing at a significant CAGR during the forecast period. The Canada erectile dysfunction treatment market is mainly driven by the increasing awareness about erectile dysfunction, as well as the rising incidence of erectile dysfunction. Approximately, 50% of men between the age group of 40-70 years gets affected by erectile dysfunction. Advancements in the currently available treatment options are also driving the growth of the Canada erectile dysfunction treatment market.
The erectile dysfunction treatment market is segmented on the basis of treatment type and end-user. Based on the treatment type, the industry is categorized as drugs and devices. Among these, the drugs segment dominated the Canada erectile dysfunction treatment market in the year 2018, with a market share of 91.9%. The drugs segment is expected to grow with a CAGR of 5.1% during the forecast period. There are various developments in erectile dysfunction drugs to cure the disease. The major drugs used for erectile dysfunction treatment include Sildenafil, Tadalafil, and Vardenafil.
By Treatment Type
By End User
Key players in Canada Erectile Dysfunction Treatment market:
Ask for free product review call with the author
Share your specific research requirements for a customized report
Request for due diligence and consumer centric studies
Request for study updates, segment specific and country level reports
Table of Content
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key End-user
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Approach Adopted
1.3.4.1 Top-Down Approach
1.3.4.2 Bottom-Up Approach
1.3.5 Assumptions
1.4 Market Segmentation Scope
Chapter 2 Executive Summary
2.1 Market Summary
2.1.1 Canada Erectile Dysfunction Treatment Market, 2016-2026, (US$ Mn)
2.1 Market Snapshot: Canada Erectile Dysfunction Treatment Market
2.2 Market Dynamics
2.3 Canada Erectile Dysfunction Treatment Market, by Segment, 2018
2.3.1 Canada Erectile Dysfunction Treatment Market, by Treatment Type, 2018, (US$ Mn)
2.3.2 Canada Erectile Dysfunction Treatment Market, by End-user, 2018 (US$ Mn)
Chapter 3 Market Dynamics
3.1 Market Overview
3.2 Market Drivers
3.2.1 Increasing awareness about erectile dysfunction
3.2.1 Rising incidence of erectile dysfunction
3.3 Market Restraints
3.3.1 Social stigma associated with erectile dysfunction
3.4 Market Opportunities
3.4.1 Advancement in the treatment options for erectile dysfunction
3.5 Industry SWOT Analysis
Chapter 4 Canada Erectile Dysfunction Treatment Market, by Treatment Type
4.1 Market Overview, by Treatment Type
4.1.1 Canada Erectile Dysfunction Treatment Market, by Treatment Type, 2016-2026 (US$ Mn)
4.1.2 Incremental Opportunity, by Treatment Type, From 2018-2026
4.2 Drugs
4.2.1 Canada Erectile Dysfunction Treatment Market, by Drugs, 2016-2026, (US$ Mn)
4.3 Devices
4.3.1 Canada Erectile Dysfunction Treatment Market, by Devices, 2016-2026, (US$ Mn)
Chapter 5 Canada Erectile Dysfunction Treatment Market, by End-user
5.1 Market Overview, by End-user
5.1.1 Canada Erectile Dysfunction Treatment Market, by End-user, 2016-2026 (US$ Mn)
5.1.2 Incremental Opportunity, by End-user, From 2018-2026
5.2 Hospitals
5.2.1 Canada Erectile Dysfunction Treatment Market, by Hospitals, 2016-2026, (US$ Mn)
5.3 Speciality Clinics (ED Clinics)
5.3.1 Canada Erectile Dysfunction Treatment Market, by Speciality Clinics (ED Clinics), 2016-2026, (US$ Mn)
5.4 Others
5.4.1 Canada Erectile Dysfunction Treatment Market, by Others, 2016-2026, (US$ Mn)
Chapter 6 Competitive Intelligence
6.1 Market Players Present in Market Life Cycle
6.2 Top 5 Players Comparison
6.3 Market Positioning of Key Players, 2018
6.4 Market Players Mapping
6.4.1 By Treatment Type
6.4.2 By End-user
6.5 Strategies Adopted by Key Market Players
6.6 Recent Developments in the Market
6.6.1 Mergers & Acquisitions, Partnership, New Product Developments
6.7 Operational Efficiency Comparison by Key Players
Chapter 7 Company Profiles
7.1 Coloplast Group
7.1.1 Coloplast Group Overview
7.1.2 Key Stakeholders/Person in Coloplast Group
7.1.3 Coloplast Group Products Portfolio
7.1.4 Coloplast Group Financial Overview
7.1.5 Coloplast Group News/Recent Developments
7.2 Boston Scientific Corporation
7.2.1 Boston Scientific Corporation Overview
7.2.2 Key Stakeholders/Person in Boston Scientific Corporation
7.2.3 Boston Scientific Corporation Products Portfolio
7.2.4 Boston Scientific Corporation Financial Overview
7.2.5 Boston Scientific Corporation News/Recent Developments
7.3 Zephyr Surgical Implants SARL
7.3.1 Zephyr Surgical Implants SARL Overview
7.3.2 Key Stakeholders/Person in Zephyr Surgical Implants SARL
7.3.3 Zephyr Surgical Implants SARL Products Portfolio
7.3.4 Zephyr Surgical Implants SARL Financial Overview
7.3.5 Zephyr Surgical Implants SARL News/Recent Developments
7.4 Medispec
7.4.1 Medispec Overview
7.4.2 Key Stakeholders/Person in Medispec
7.4.3 Medispec Products Portfolio
7.4.4 Medispec Financial Overview
7.4.5 Medispec News/Recent Developments
7.5 KARL STORZ SE & Co. KG
7.5.1 KARL STORZ SE & Co. KG Overview
7.5.2 Key Stakeholders/Person in KARL STORZ SE & Co. KG
7.5.3 KARL STORZ SE & Co. KG Products Portfolio
7.5.4 KARL STORZ SE & Co. KG Financial Overview
7.5.5 KARL STORZ SE & Co. KG News/Recent Developments
7.6 Augusta Medical Systems LLC
7.6.1 Augusta Medical Systems LLC Overview
7.6.2 Key Stakeholders/Person in Augusta Medical Systems LLC
7.6.3 Augusta Medical Systems LLC Products Portfolio
7.6.4 Augusta Medical Systems LLC Financial Overview
7.6.5 Augusta Medical Systems LLC News/Recent Developments
Log in / Register
